Vaginitis and risk of sexually transmitted infections: results of a multi-center U.S. clinical study using STI nucleic acid amplification testing
Journal of Clinical Microbiology · 11.09.2024 · 62 (9)
DOI: 10.1128/jcm.00816-24 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Clinical Microbiology, erschienen am 11.09.2024. Verfasst von Jane R Schwebke und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Sexually Transmitted Diseases, Nucleic Acid Amplification Techniques. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Significant increases in rates of sexually transmitted infections (STIs) caused by Trichomonas vaginalis (TV), Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Mycoplasma genitalium (MG) are occurring in the United States. We present results of a U.S. study examining the intersection of STIs and vaginitis. Among 1,051 women with diagnoses for the presence or absence of bacterial vaginosis (BV) and/or symptomatic vulvovaginal candidiasis (VVC), 195 (18.5%) had one or more STIs, including 101 (9.6%) with TV, 24 (2.3%) with CT, 9 (0.8%) with NG, and 93 (8.8%) with MG. STI prevalence in BV-positive women was 26.3% (136/518), significantly higher than STI prevalence of 12.5% (59/474) in BV-negative women ( P < 0.0002). Unlike infections with CT or NG, solo infections of MG or TV were each significantly associated with a diagnosis of BV-positive/VVC-negative (OR 3.0751; 95% CI 1.5797–5.9858, P = 0.0113, and OR 2.873; 95% CI 1.5687–5.2619, P = 0.0017, respectively) and with mixed infections containing MG and TV (OR 3.4886; 95% CI 1.8901–6.439, P = 0.0042, and OR 3.1858; 95% CI 1.809–5.6103, P = 0.0014, respectively). TV and MG infection rates were higher in all Nugent score (NS) categories than CT and NG infection rates; however, both STIs had similar comparative prevalence ratios to CT in NS 6–10 vs NS 0–5 (CT: 3.06% vs 1.4%, 2.2-fold; MG: 10.7% vs 6.1%, 1.8-fold; TV: 14.5% vs 7.0%, 2.1-fold). NG prevalence was relatively invariant by the NS category. These results highlight the complexity of associations of STIs with two major causes of vaginitis and underscore the importance of STI testing in women seeking care for abnormal vaginal discharge and inflammation. IMPORTANCE This study reports high rates for sexually transmitted infections (STIs) in women seeking care for symptoms of vaginitis and bacterial vaginosis, revealing highly complex associations of STIs with two of the major causes of vaginal dysbiosis. These results underscore the importance of STI testing in women seeking care for abnormal vaginal discharge and inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
- Hologic, Inc., San Diego, California, USA.
ORCID-Profile: Damon Getman
Zitieren
APA
Schwebke, J. R., Nyirjesy, P., Dsouza, M., & Getman, D. (2024). Vaginitis and risk of sexually transmitted infections: results of a multi-center U.S. clinical study using STI nucleic acid amplification testing. Journal of Clinical Microbiology, 62(9). https://doi.org/10.1128/jcm.00816-24
Vancouver
Schwebke JR, Nyirjesy P, Dsouza M, Getman D. Vaginitis and risk of sexually transmitted infections: results of a multi-center U.S. clinical study using STI nucleic acid amplification testing. Journal of Clinical Microbiology. 2024;62(9). doi:10.1128/jcm.00816-24
BibTeX
@article{Schwebke2024,
author = {Schwebke, Jane R and Nyirjesy, Paul and Dsouza, Melissa and Getman, Damon},
title = {Vaginitis and risk of sexually transmitted infections: results of a multi-center U.S. clinical study using STI nucleic acid amplification testing},
journal = {Journal of Clinical Microbiology},
year = {2024},
volume = {62},
number = {9},
doi = {10.1128/jcm.00816-24}
}
EUVIMED